Bonesupport Holding (Sweden) Performance
| BONEX Stock | SEK 370.00 1.80 0.48% |
On a scale of 0 to 100, Bonesupport Holding holds a performance score of 9. The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bonesupport Holding's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bonesupport Holding is expected to be smaller as well. Please check Bonesupport Holding's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Bonesupport Holding's price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bonesupport Holding AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Bonesupport Holding unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 353.7 M | |
| Total Cashflows From Investing Activities | -3.4 M |
Bonesupport |
Bonesupport Holding Relative Risk vs. Return Landscape
If you would invest 30,300 in Bonesupport Holding AB on August 31, 2024 and sell it today you would earn a total of 6,700 from holding Bonesupport Holding AB or generate 22.11% return on investment over 90 days. Bonesupport Holding AB is generating 0.3512% of daily returns and assumes 2.7981% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Bonesupport, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bonesupport Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bonesupport Holding's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bonesupport Holding AB, and traders can use it to determine the average amount a Bonesupport Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1255
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BONEX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.8 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Bonesupport Holding is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bonesupport Holding by adding it to a well-diversified portfolio.
Bonesupport Holding Fundamentals Growth
Bonesupport Stock prices reflect investors' perceptions of the future prospects and financial health of Bonesupport Holding, and Bonesupport Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bonesupport Stock performance.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.25) % | |||
| Operating Margin | (0.27) % | |||
| Current Valuation | 5.29 B | |||
| Shares Outstanding | 64.55 M | |||
| Price To Book | 19.34 X | |||
| Price To Sales | 18.59 X | |||
| Revenue | 212.88 M | |||
| EBITDA | (72.39 M) | |||
| Cash And Equivalents | 206.46 M | |||
| Cash Per Share | 3.34 X | |||
| Total Debt | 16.15 M | |||
| Debt To Equity | 6.10 % | |||
| Book Value Per Share | 4.39 X | |||
| Cash Flow From Operations | (83.42 M) | |||
| Earnings Per Share | (1.27) X | |||
| Total Asset | 343.92 M | |||
About Bonesupport Holding Performance
Assessing Bonesupport Holding's fundamental ratios provides investors with valuable insights into Bonesupport Holding's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bonesupport Holding is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Bonesupport Holding AB , an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids Sweden and internationally. The company was founded in 1999 and is headquartered in Lund, Sweden. BONESUPPORT HOLDING operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 78 people.Things to note about Bonesupport Holding performance evaluation
Checking the ongoing alerts about Bonesupport Holding for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bonesupport Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 212.88 M. Net Loss for the year was (80.67 M) with profit before overhead, payroll, taxes, and interest of 189.7 M. | |
| Bonesupport Holding AB has accumulated about 206.46 M in cash with (83.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34. | |
| Roughly 13.0% of the company shares are held by company insiders |
- Analyzing Bonesupport Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bonesupport Holding's stock is overvalued or undervalued compared to its peers.
- Examining Bonesupport Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bonesupport Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bonesupport Holding's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bonesupport Holding's stock. These opinions can provide insight into Bonesupport Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bonesupport Stock Analysis
When running Bonesupport Holding's price analysis, check to measure Bonesupport Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonesupport Holding is operating at the current time. Most of Bonesupport Holding's value examination focuses on studying past and present price action to predict the probability of Bonesupport Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonesupport Holding's price. Additionally, you may evaluate how the addition of Bonesupport Holding to your portfolios can decrease your overall portfolio volatility.